114 related articles for article (PubMed ID: 1919650)
21. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer.
Bach F; Bjerregaard B; Sölétormos G; Bach FW; Horn T
Cancer; 1993 Oct; 72(8):2376-82. PubMed ID: 8402452
[TBL] [Abstract][Full Text] [Related]
22. Immunodiagnosis of the primary brain tumor (glioma) by the endogenous lectin.
Basu PS; Majhi R; Ghosh S; Ghosh B; Batabyal SK
Clin Chim Acta; 2002 Mar; 317(1-2):177-80. PubMed ID: 11814473
[TBL] [Abstract][Full Text] [Related]
23. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
Wikstrand CJ; Bigner SH; Bigner DD
Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
[TBL] [Abstract][Full Text] [Related]
24. Malignancy markers in the cerebrospinal fluid.
Koskiniemi M
Eur J Pediatr; 1988 Oct; 148(1):3-8. PubMed ID: 3058481
[TBL] [Abstract][Full Text] [Related]
25. Primary diffuse leptomeningeal gliomatosis diagnosed on CSF cytology: perseverance pays off.
Louapre C; Desestret V; Mokhtari K; Lubetzki C
Pract Neurol; 2015 Apr; 15(2):138-40. PubMed ID: 25246603
[No Abstract] [Full Text] [Related]
26. Paucity of humoral response in patients to glioma-associated antigen(s): antigen localization by immunofluorescence.
Fischer DK; Matsuda M; Shaban F; Narayan RK; Atassi MZ
Adv Exp Med Biol; 1991; 303():263-70. PubMed ID: 1805570
[TBL] [Abstract][Full Text] [Related]
27. Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.
Meng Q; Luo G; Liu B; Sun Y; Yan Z
Neoplasma; 2018; 65(4):604-609. PubMed ID: 30064232
[TBL] [Abstract][Full Text] [Related]
28. [Biomarkers of glioma: recent advance and potential applications].
Yu SZ; Wang Q
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
[No Abstract] [Full Text] [Related]
29. Radioimmunoassay of astroprotein (an astrocyte-specific cerebroprotein) in cerebrospinal fluid and its clinical significance.
Mori T; Morimoto K; Hayakawa T; Ushio Y; Mogami H; Sekiguchi K
Neurol Med Chir (Tokyo); 1978; 18(1 Pt 1):25-31. PubMed ID: 77492
[No Abstract] [Full Text] [Related]
30. Primary leptomeningeal gliomatosis: symptoms suggestive of meningitis.
Ho KL; Hoschner JA; Wolfe DE
Arch Neurol; 1981 Oct; 38(10):662-6. PubMed ID: 7295114
[TBL] [Abstract][Full Text] [Related]
31. Partial purification and characterization of a murine glioma-associated antigen defined by syngeneic rat monoclonal antibodies.
Lee YS; Matthews TJ; Pizzo S; Abernethy JL; Bigner DD
J Neuroimmunol; 1986 Dec; 13(2):203-16. PubMed ID: 2430998
[TBL] [Abstract][Full Text] [Related]
32. Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls.
Fischer U; Struss AK; Hemmer D; Pallasch CP; Steudel WI; Meese E
Clin Exp Immunol; 2001 Nov; 126(2):206-13. PubMed ID: 11703362
[TBL] [Abstract][Full Text] [Related]
33. Radioimmunoassay of astroprotein (an astrocyte-specific cerebroprotein) in cerebrospinal fluid from patients with glioma. A preliminary study.
Mori T; Morimoto K; Ushio Y; Hayakawa T; Mogami H
Neurol Med Chir (Tokyo); 1975; 15 pt 1():23-5. PubMed ID: 60716
[No Abstract] [Full Text] [Related]
34. [Use of radioimmunoanalysis for tumor markers in the diagnosis of carcinoma of the testes and prostate].
Kausitz J
Bratisl Lek Listy; 1988 Oct; 89(10):715-24. PubMed ID: 2463063
[No Abstract] [Full Text] [Related]
35. [Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines].
Kausitz J
Bratisl Lek Listy; 1988 Aug; 89(8):563-76. PubMed ID: 3179762
[No Abstract] [Full Text] [Related]
36. [Fundamental and clinical evaluation of IRMA for serum pancreatic oncofetal antigen (POA)].
Murakami M; Fukuchi M
Kaku Igaku; 1988 Feb; 25(2):161-9. PubMed ID: 3164428
[No Abstract] [Full Text] [Related]
37. Comparison of CA19-9 with other tumor markers in the diagnosis of cancer of the pancreas.
Satake K; Takeuchi T
Pancreas; 1994 Nov; 9(6):720-4. PubMed ID: 7846015
[TBL] [Abstract][Full Text] [Related]
38. Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumour.
Yoshida J; Wakabayashi T; Okamoto S; Kimura S; Washizu K; Kiyosawa K; Mokuno K
J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1212-5. PubMed ID: 7523604
[TBL] [Abstract][Full Text] [Related]
39. [Fundamental studies of a pancreatic oncofetal antigen immunoradiometric assay kit].
Nagata A; Komoda T
Kaku Igaku; 1988 Dec; 25(12):1445-55. PubMed ID: 3249464
[No Abstract] [Full Text] [Related]
40. [The clinical evaluation of prostatic specific antigen in prostatic cancer].
Hiromoto Y; Hiramori M; Higaki Y; Imammura K
Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):606-12. PubMed ID: 2465428
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
